MediPharm Labs Corp. (TSX:LABS) (OTCQX: MEDIF) (FSE:MLZ) generated C$6.1 million ($4.85 million) in the fourth quarter of 2020, up by 22% sequentially.
The Barrie, Ontario-based company, wrapped up 2020 with C$36 million in revenue.
The bet loss amounted to roughly C$30.9 million for the quarter, compared to C$15.4 million in the prior period. For the full year, the net loss was C$72.1 million.
The company posted negative adjusted EBITDA (a non-IFRS measure) of C$8.7 million, compared to a C$7.26 million …
